VectorBuilder, Inc.

VectorBuilder | Revolutionize Gene Delivery from Research to Therapy

San Francisco, United States · $57.0M raised

Headquarters
San Francisco
Total Funding
$57.0M
Last Round
$57.0M Series COct 2022
Rounds
1

About

VectorBuilder is a Leading Provider of Recombinant Vectors and Viruses, Offering a Wide Range Gene Delivery Solutions Tailored to Your Project Needs.

Summary

VectorBuilder, Inc. is a Biotech company based in San Francisco, United States. It has raised $57.0M in total across 1 round, most recently a $57.0M Series C round in Oct 2022. Investors include Legend Capital and Guangzhou Yuexiu Industrial Investment Fund Management.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries COct 2022
$57.0M

Investors

Similar Companies